1. Surface modified and rituximab functionalized PAMAM G4 nanoparticle for targeted imatinib delivery to leukemia cells: In vitro studies
   Parastoo Fotouhi et al, 2021, Process Biochemistry CrossRef
2. Intracellular pH-responsive and rituximab-conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells
   Shoubing Zhou et al, 2017, Journal of Experimental & Clinical Cancer Research CrossRef
3. Recent Progress of Doxorubicin Nanomedicine in Hematologic Malignancies
   Ying Qu et al, 2017, Nanoscience and Nanotechnology Letters CrossRef
4. PD-L1-targeted microbubbles loaded with docetaxel produce a synergistic effect for the treatment of lung cancer under ultrasound irradiation
   Tiankuan Li et al, 2020, Biomaterials Science CrossRef
5. High in Vitro Anti-Tumor Efficacy of Dimeric Rituximab/Saporin-S6 Immunotoxin
   Massimo Bortolotti et al, 2016, Toxins CrossRef
6. Targeted microbubbles with ultrasound irradiation and PD-1 inhibitor to increase antitumor activity in B-cell lymphoma
   Shiya Zheng et al, 2018, Nanomedicine CrossRef
7. Advances and Prospects of Ultrasound Targeted Drug Delivery Systems Using Biomaterial-modified Micro/Nanobubbles for Tumor Therapy
   Chen Lin et al, 2022, Current Medicinal Chemistry CrossRef
8. Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cells
   Jaleh Varshosaz et al, 2021, Journal of Liposome Research CrossRef
9. Encapsulation of Imatinib in Targeted KIT-5 Nanoparticles for Reducing its Cardiotoxicity and Hepatotoxicity
   Jaleh Varshosaz et al, 2020, Anti-Cancer Agents in Medicinal Chemistry CrossRef